Taft attorneys Stephen Auten, Anthony E. Dowell and Richard T. Ruzich will be panelists at the American Conference Institute's 8th Annual Paragraph IV Disputes Conference, held April 28-29, 2014, in New York City.

• Steve Auten will be a panelist for the session titled "Assessing Pharmaceutical Patent Sustainability and Vulnerability: Strategies and Considerations for Brand Names and Generics in Anticipating, Identifying and Determining Which Patents Will Be Ripe for Challenges of Invalidity and Non-Infringement."
• Tony Dowell will be a panelist for the session titled "Ethical Considerations for Paragraph IV Matters Before the PTO and District Courts: Inequitable Conduct and More."
• Richard Ruzich will be a panelist for the session titled "Looking Beyond 180 Days: New Exclusivity Challenges for Brand Names and Generics and Related Implications for Paragraph IV Challenges."

The event is known as the pharmaceutical industry's leading forum on Hatch-Waxman litigation. Taft will sponsor the breakfast on April 28. To register or learn more about this event, please click here.